How We Rate Sermorelin Providers
Our editorial team evaluates every provider across five independently weighted criteria. Here is exactly what we measure and why.
Our Approach
There are dozens of telehealth providers offering compounded sermorelin, and the differences between a quality program and a lower-quality one are not obvious from a homepage. We built this methodology to give patients a consistent, transparent basis for comparison.
Our team evaluates each provider independently. Scores are determined by the criteria below and are not influenced by advertising relationships. Providers featured on this site may pay listing fees, which can affect placement, but not the score assigned.
Our Rating Methodology
Each provider is evaluated across five criteria. Weights reflect the relative clinical importance of each factor in determining patient safety and outcomes.
Medical Oversight & Physician Credentials
30% of total scoreThe most weighted criterion. Sermorelin is a prescription medication, and the clinical quality of the prescribing physician is a primary factor in patient safety and protocol effectiveness.
Board Certification
We verify that physicians supervising sermorelin protocols hold board certification in internal medicine, endocrinology, family medicine, or an equivalent specialty. Telehealth platforms staffed solely by nurse practitioners score lower in this category.
Hormone Therapy Specialization
We give additional weight to providers whose clinical team has documented experience in hormone and metabolic medicine, including GH axis disorders and age-related hormone decline in adults.
Consultation Quality
We evaluate the depth of the initial consultation, including whether it covers health history, current medications, and contraindications. Providers that move from consultation to prescription without addressing these variables score lower.
Ongoing Physician Involvement
We assess whether a physician remains actively involved after the initial prescription, including reviewing 90-day labs, adjusting doses, and remaining accessible to the patient. Programs that operate without follow-up physician contact score lower.
Pharmacy Standards & Compounding Quality
25% of total scoreCompounded sermorelin quality varies by pharmacy. The source of the peptide is a relevant factor in treatment consistency.
503A vs 503B Registration
We verify that providers source compounded sermorelin from a state-licensed 503A or FDA-registered 503B outsourcing facility. 503B facilities operate under stricter federal quality standards and are the preferred source for consistent peptide potency.
Sterile Manufacturing
Sermorelin is administered by subcutaneous injection. We confirm that the compounding pharmacy operates a sterile manufacturing environment compliant with USP 797 standards, which govern microbial and endotoxin limits for injectable compounds.
Pharmacy Transparency
Quality providers disclose which pharmacy compounds their sermorelin without hesitation. We flag providers that cannot or will not name their pharmacy. This is public information and any program that deflects the question raises a concern worth investigating.
Lab Testing & Clinical Monitoring
20% of total scorePrescribing sermorelin without baseline labs removes the clinical data needed to confirm whether treatment is appropriate. Monitoring also determines whether the protocol is producing a measurable response.
Baseline IGF-1 Requirement
We require that providers order a baseline IGF-1 panel before prescribing. IGF-1 is a primary downstream marker of GH axis activity and a key objective measure of whether treatment is indicated for a given patient.
90-Day Follow-Up Labs
We evaluate whether a 90-day IGF-1 retest is included in the program or available at a stated cost. This is the standard follow-up interval for assessing dose response and confirming that the prescribed protocol is producing a measurable effect.
Lab Bundling & Cost
We note whether lab costs are included in the monthly plan or billed separately. Programs that bundle labs into the plan tend to support better clinical continuity than programs that treat each lab draw as an optional add-on.
Pricing Transparency
15% of total scoreThe all-in monthly cost is the figure we report. We flag programs that advertise a low entry price while adding consultation fees, lab costs, and shipping as separate line items.
Pre-Consultation Pricing
We give full marks to providers that publish all-in pricing before any consultation call. Providers that reveal pricing only after speaking to a staff member lose points in this category, regardless of how competitive their final price is.
Fee Structure Clarity
We document whether the advertised price includes consultation fees, lab costs, medication, and shipping, or whether each is an additional line item. Total cost is what we report, not the lowest advertised number.
Cancellation Policy
We review whether providers publish a clear cancellation and refund policy before sign-up. Programs that require patients to call to cancel, or that do not publish refund terms upfront, score lower in this category.
Patient Support & Accessibility
10% of total scoreThe level of support available during dose titration and ongoing treatment is a relevant factor in patient experience and protocol adherence.
Provider Messaging
We evaluate whether patients can message a physician or clinical team member asynchronously without scheduling a paid appointment. For a medication that requires dose titration over several months, accessible provider communication is a meaningful differentiator.
Response Time
We assess how quickly providers respond to patient inquiries and whether response time expectations are stated. Same-day or next-business-day responses indicate adequate clinical staffing.
Platform Usability
We evaluate the ease of managing prescriptions, requesting refills, reviewing labs, and communicating with the clinical team through the provider platform or app.
How Final Scores Are Assigned
Each provider is evaluated against the five criteria above. The weighted scores are summed to produce a raw evaluation result. The provider with the highest raw score receives a published score of 9.9. The second-highest receives 9.8, the third 9.7, and so on. Published scores reflect relative performance across the reviewed field, not an absolute grading scale.
Advertising Fees and Editorial Independence
SermorelinOnline.com receives advertising fees from the providers featured on this site. These fees may influence which providers are listed and the order in which they appear. Scoring criteria are applied consistently and independently of any commercial relationship. Compensation does not affect the criteria used in our evaluations or the scores assigned. Providers cannot purchase a higher score.
For full details, see our Advertising Disclosure and Medical Disclaimer.